What's Hot
View all perspectives
Richard Conway RichardPAConway
2 years 5 months ago
Sanchez-Bilboa at al. IV vs SC tocilizumab in 471 GCA patients. Equal efficacy. The authors report more adverse events with IV but actually this was purely due to longer follow up and per patient years it was the same. @RheumNow #EULAR2022 POS0272 https://t.co/2h7iIkMxjW
Dr. John Cush RheumNow
2 years 5 months ago
Just try and get into the great Tivoli Gardens after a day at #EULAR2022 https://t.co/qsGln5nH6S
Richard Conway RichardPAConway
2 years 5 months ago
Yusof et al @Yuz6Yusof COVID-19 in RTX treated patients. Significant efficacy of vaccination in both overall and severe COVID rates. Vaccination decreased risk HR 0.13 (0.03-0.51). Number comorbidities and low IgG increase risk @RheumNow #EULAR2022 OP0250 https://t.co/yD1tvs1UYt https://t.co/23XTtPb8fD
ARD & RMD Open ARD_BMJ
2 years 5 months ago
Pharmacodynamic effect of sequential #belimumab and #rituximab therapy in patients with systemic #lupus: BLISS-BELIEVE study
#EULAR2022
>CR https://t.co/AgBBuqYatW
David Liew drdavidliew
2 years 5 months ago
#EULAR2022 virtual from my Copenhagen apartment this morning - you can’t watch three concurrent streams in person! @RheumNow https://t.co/Z74EOPn7kW
Richard Conway RichardPAConway
2 years 5 months ago
WIN-Lupus. RCT of stopping treatment in SLE. All on HCQ. Randomised to stop Aza/MMF after being stable on for 2-3 years. Relapse proliferative nephritis in 25% vs 10%. Severe SLE flare 32% vs 13%. @RheumNow #EULAR2022 OP0280 https://t.co/IAcCoKw1YI
Emre Bilgin, MD dr_emrebilgin
2 years 5 months ago
It was a pleasure to eat with editors of @RheumJnl at the first evening of #EULAR2022 @LatikaGupta_ @drdj @docrota @SteZhao @ElenaNikiUK
Best Rheumatology journal 🥳🥳 https://t.co/oTDWRUh0Fb
David Liew drdavidliew
2 years 5 months ago
So maybe, when it comes to delivering healthcare and telemedicine, we need to think about quality and efficiency? #EULAR2022 @RheumNow https://t.co/JMbQ1ZUB0o
David Liew drdavidliew
2 years 5 months ago
and, Robert Landewe argues, telemedicine is merely exchanging parcels of information.
Life visits deliver the chance for empathy #EULAR2022 @RheumNow https://t.co/2CKTJHfF7A
David Liew drdavidliew
2 years 5 months ago
Quality patient communication is actually critical to outcome #EULAR2022 @RheumNow https://t.co/37Z7hwrWmX
David Liew drdavidliew
2 years 5 months ago
What's the argument against that?
Fundamentally, empathy. The patient experience isn't just a product of miracle drugs - over time it's a multitude of factors that are what leads to happy patients
#EULAR2022 @RheumNow https://t.co/8GwhdT8cit
David Liew drdavidliew
2 years 5 months ago
and if we don't act, we leave it to the wild, wild west of the private market:
- designed for profit (not necessarily bad)
- but often at the cost of robust dedication to patient outcomes (always bad)
#EULAR2022 @RheumNow https://t.co/zfJWTZ3I1G
David Liew drdavidliew
2 years 5 months ago
In fact, in some select situations we can get by very well without seeing our patient at all?
#EULAR2022 @RheumNow https://t.co/4qcaj2KR9B
David Liew drdavidliew
2 years 5 months ago
So maybe telemedicine can bring us the efficiency that we badly need. In rheumatology, we're drowning in demand - is telemedicine part of the solution?
#EULAR2022 @RheumNow https://t.co/kHBIYRIvBA
Ashima Makol MD AshimaMakol
2 years 5 months ago
✨ Inflammatory #Myositis✨
👉 Excellent summary of Autoantibodies, Immune alterations and Distinct Phenotypes by Dr. Lisa Rider
#EULAR2022 https://t.co/KLzmLUGk9Z
Poster Hall